Use of novel oral anticoagulants in patients undergoing atrial fibrillation catheter ablation

被引：0
|
作者：
John, S. [1 ]
Sommer, P. [1 ]
Arya, A. [1 ]
Richter, S. [1 ]
Dinov, B. [1 ]
Rolf, S. [1 ]
Eitel, C. [1 ]
Hindricks, G. [1 ]
Bollmann, A. [1 ]
机构：
[1] Ctr Heart, Dept Electrophysiol, Leipzig, Germany
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6265
引用
收藏
页码：1112 / 1112
页数：1
相关论文
共 50 条
  • [41] Meta-analysis of efficacy and safety of new oral anticoagulants compared with warfarin in Japanese patients undergoing catheter ablation for atrial fibrillation
    Yuchao Sun
    Xiaohua Liu
    Yizhou Xu
    Journal of Interventional Cardiac Electrophysiology, 2020, 58 : 381 - 399
  • [42] Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation
    Providencia, Rui
    Marijon, Eloi
    Albenque, Jean-Paul
    Combes, Stephane
    Combes, Nicolas
    Jourda, Francois
    Hireche, Hassiba
    Morais, Joao
    Boveda, Serge
    EUROPACE, 2014, 16 (08): : 1137 - 1144
  • [43] Demographic Profile of Patients Undergoing Catheter Ablation of Atrial Fibrillation
    Hoyt, Hana
    Nazarian, Saman
    Alhumaid, Fawaz
    Dalal, Darshan
    Chilukuri, Karuna
    Spragg, David
    Henrikson, Charles A.
    Sinha, Sunil
    Cheng, Alan
    Edwards, David
    Needleman, Matthew
    Marine, Joseph E.
    Berger, Ronald
    Calkins, Hugh
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2011, 22 (09) : 994 - 998
  • [44] Demographic Profile of Patients Undergoing Catheter Ablation of Atrial Fibrillation
    Hoyt, H.
    Nazarian, S.
    Alhumaid, F.
    Spragg, D.
    Henrikson, C. A.
    Sinha, S.
    Cheng, A.
    Marine, J. E.
    Berger, R.
    Calkins, H.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2011, 22 (04) : 495 - 495
  • [45] PERIPROCEDURAL DABIGATRAN IN PATIENTS UNDERGOING CATHETER ABLATION FOR ATRIAL FIBRILLATION
    Khan, Saadat
    Duggal, Manoj
    Dunskis, Paula
    Bhan, Adarsh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E401 - E401
  • [46] Meta-analysis of safety and efficacy of oral anticoagulants in patients requiring catheter ablation for atrial fibrillation
    Rahman, Hammad
    Khan, Safi U.
    DePersis, Michael
    Hammad, Tehseen
    Nasir, Fahad
    Kaluski, Edo
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2019, 20 (02) : 147 - 152
  • [47] Nationwide survey of catheter ablation for atrial fibrillation: The Japanese catheter ablation registry of atrial fibrillation (J-CARAF)-A report on periprocedural oral anticoagulants
    Murakawa, Yuji
    Nogami, Akihiko
    Shoda, Morio
    Inoue, Koichi
    Naito, Shigeto
    Kumagai, Koichiro
    Miyauchi, Yasushi
    Yamane, Teiichi
    Morita, Norishige
    Mitamura, Hideo
    Okumura, Ken
    JOURNAL OF ARRHYTHMIA, 2015, 31 (01) : 29 - 32
  • [48] Use of Dronedarone and Periprocedural Stroke Risk in Patients Undergoing Catheter Ablation for Atrial Fibrillation
    Saglam, Nertila Poci
    Gjermeni, Diona
    Kuehlkamp, Volker
    CIRCULATION, 2021, 144
  • [49] Interruption of oral anticoagulants after atrial fibrillation catheter ablation: the importance of risk stratification
    Brienesse, Stephen
    Passman, Rod
    Freedman, Ben
    EUROPEAN HEART JOURNAL, 2024, 45 (07) : 535 - 537
  • [50] Uninterrupted Direct Oral Anticoagulants in Atrial Fibrillation Catheter Ablation: Ready for Prime Time
    Cardoso, Rhanderson
    D'Avila, Andre
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 114 (03) : 443 - 445
12345